Navigation Links
VICAM's New Immunoassay Column Detects Seven Mycotoxins in Single Run
Date:4/2/2013

MILFORD, Mass., April 2, 2013 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced that VICAM®, a Waters® Business, introduced the Myco6in1+™ LC/MS/MS immunoaffinity (IA) column, the only IA column on the market to simultaneously screen for seven major mycotoxin families isolating at least 14 chemically-distinct mycotoxins, including aflatoxin, ochratoxin A, fumonisin, deoxynivalenol, zearalenone, T-2, HT-2, and nivalenol.

(Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO )

Created by VICAM, the world's leading provider of mycotoxin testing solutions, the Myco6in1+ column is a quantitative tool which combines the proven strengths of selective monoclonal antibodies and liquid chromatography with tandem mass spectrometry. It is designed to deliver precise numerical results, with a recovery rate greater than 90%.

Marjorie Radlo-Zandi , General Manager, Director of Operations of VICAM said, "VICAM's patented Myco6n1+ technology provides both ease of use and superior recovery. This provides analytic labs with an effective tool in order to test for multiple mycotoxins even with the most complex of commodity matrices. Our patented new multi-analyte column provides superior measurable results, while also giving sample throughput and overall efficiency a major boost."  

The Myco6in1+ column requires only one sample and a single pass through the column, minimizing time and materials costs while improving laboratory productivity. Independent labs can now use it as a routine analysis tool because it is fast and simple with excellent recoveries.

Mycotoxins are naturally occurring chemical byproducts of ubiquitous mold species which are natural inhabitants of crop soils. Severe rain or drought can encourage mycotoxin production and, once released, mycotoxins are difficult to manage and virtually impossible to destroy.  The USDA, FDA, EU, and other international government agencies impose specific regulations and guidelines for acceptable levels of mycotoxins. Producers and exporters use on site and laboratory testing to ensure regulatory compliance and to protect human and animal health.

For more information on the Myco6in1+ column, please visit www.vicam.com/myco

About VICAM, A Waters Business (www.vicam.com)

VICAM is a world-leading provider of mycotoxin testing solutions. Since 1985, VICAM has been dedicated to developing USDA- and AOAC-approved rapid tests for mycotoxins. VICAM's mycotoxin test kits offer a choice of rapid qualitative screening and quantitative test methods for a wide variety of mycotoxins. Around the world, VICAM products are used with confidence by customers who trust our commitment to extending the value of those products with unmatched service and support. We guarantee satisfaction with expert technical assistance and top-of-the-line customer care through a global scientific and distribution network that develops, markets, sells, and services our products in more than 100 countries. For more information, please visit www.vicam.com or call +1.508.482.4935.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE: WAT) creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters' technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.84 billion in 2012, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters and VICAM are registered trademarks of Waters Corporation.  Myco6in1+ is a trademark of Waters Corporation.


'/>"/>
SOURCE Waters Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
2. The Return of Extinct Animals – and Maybe Humans; Latest Topic by HuffPost Columnist and Sociologist Gini Graham Scott
3. Graphene foam detects explosives, emissions better than todays gas sensors
4. Study In Prenatal Diagnosis Finds Sequenom CMMs MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets
5. DNA Blood Test Detects Cancer Resistance Using Inostics BEAMing Technology
6. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
7. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
8. NDIA, NTSA Will Be On Hand At Seventh Annual Capitol Hill Modeling and Simulation Expo, Set To Focus On Homeland Security, First Response
9. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
10. Seven Outstanding Doctors Receive Honors From The United States & Canadian Academy of Pathology
11. New England Biolabs opens seventh subsidiary in Singapore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... different cell type. Many treatments for specific cancers, such as breast, prostate, or ... treatment is androgen deprivation therapy for advanced prostate cancer. , This therapy ...
(Date:8/16/2017)... year,s edition of the Inc. 5000 features a now-familiar name: BioPoint ( ... the list for the third year in a row. Now in its ... on a set of quantitative metrics. In addition, BioPoint was also named ... Bay State . ... 5000 ...
(Date:8/15/2017)... ... 15, 2017 , ... Nanomedical Diagnostics , a cutting-edge ... the launch of the new NHS Agile biosensor chip . The new ... a wide range of molecules, including small and large molecules, peptides, proteins, and ...
(Date:8/15/2017)... ... , ... The Conference Forum and The Trout Group ... of upcoming panels and events. The partnership culminates with the 4th Annual IO360° ... York City. , “With our experience in producing the Immuno-Oncology 360° NYC event and ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
Breaking Biology News(10 mins):